European Union - English - EMA (European Medicines Agency)

hra pharma rare diseases - mitotane - adrenal cortex neoplasms - antineoplastic agents - symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma. the effect of lysodren on non-functional adrenal cortical carcinoma is not established.

Israel - English - Ministry of Health

cts ltd - mitotane - tablets - mitotane 500 mg - mitotane - symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma (acc).

Canada - English - Health Canada

hra pharma rare diseases - mitotane - tablet - 500mg - mitotane 500mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hra pharma uk ltd - mitotane - tablet - 500mg